Financial Ratios | Caplin Point Laboratories Ltd. | R Wadiwala Securities Pvt Ltd

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1962.6510.25 (+0.52 %)
PREV CLOSE (Rs.) 1952.40
OPEN PRICE (Rs.) 1950.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3846
TODAY'S LOW / HIGH (Rs.)1942.10 1974.80
52 WK LOW / HIGH (Rs.)1551.05 2636
NSE1963.9011.9 (+0.61 %)
PREV CLOSE( Rs. ) 1952.00
OPEN PRICE (Rs.) 1952.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1963.90 (261)
VOLUME 37297
TODAY'S LOW / HIGH(Rs.) 1940.00 1975.90
52 WK LOW / HIGH (Rs.)1599 2641

Financial Ratios

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)70.5760.1849.5739.5632.03
   CEPS(Rs)79.8867.7955.6046.8838.12
   DPS(Rs)6.005.004.504.003.00
   Book NAV/Share(Rs)362.67293.21235.91183.89144.94
   Tax Rate(%)20.0518.2516.4820.0519.83
Margin Ratios
   Core EBITDA Margin(%)33.3932.5530.0331.0830.55
   EBIT Margin(%)34.9633.3630.8330.4529.70
   Pre Tax Margin(%)34.9333.3230.7730.3929.55
   PAT Margin (%)27.9327.2425.7024.3023.69
   Cash Profit Margin (%)31.3330.3928.7727.9927.17
Performance Ratios
   ROA(%)18.3718.9819.3019.9420.20
   ROE(%)21.7222.9723.6824.7725.65
   ROCE(%)26.2226.9226.8528.7728.82
   Asset Turnover(x)0.660.700.750.820.85
   Sales/Fixed Asset(x)2.482.863.172.922.73
   Working Capital/Sales(x)1.061.081.141.161.22
Efficiency Ratios
   Fixed Capital/Sales(x)0.400.350.320.340.37
   Receivable days110.70100.9288.4885.7487.41
   Inventory Days65.8670.1664.1558.4271.75
   Payable days105.8896.3184.8980.0259.05
Valuation Parameters
   PER(x)28.3821.8912.0417.1912.62
   PCE(x)25.0719.4310.7314.5010.60
   Price/Book(x)5.524.492.533.702.79
   Yield(%)0.300.380.750.590.74
   EV/Net Sales(x)7.595.622.803.752.55
   EV/Core EBITDA(x)19.7815.418.2811.007.70
   EV/EBIT(x)21.7116.869.1012.338.60
   EV/CE(x)5.164.112.182.751.99
   M Cap / Sales7.865.913.094.062.88
Growth Ratio
   Net Sales Growth(%)14.3715.5015.5419.6122.95
   Core EBITDA Growth(%)20.2124.4114.6823.0716.85
   EBIT Growth(%)19.8525.0116.9722.6216.84
   PAT Growth(%)17.2722.4022.2222.6816.90
   EPS Growth(%)17.2521.4025.3223.5212.67
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.01
   Current Ratio(x)6.975.725.796.257.10
   Quick Ratio(x)5.884.624.725.155.85
   Interest Cover(x)1110.48724.63579.65552.17198.25
   Total Debt/Mcap(x)0.000.01